Raleigh, NC (PRWEB) September 13, 2013
PCI, a leading provider of calibration and maintenance services to the Life Sciences industry is pleased to announce the recent appointment of Ken Ewan to the PCI Board. Mr. Ewan has over 40 years of experience in the biotechnology, chemical and pharmaceutical fields.
"PCI has experienced growth in every regional office this year. With the nationwide expansion of PCI services, Mr. Ewan’s leadership and coaching skills will greatly benefit our associates and our clients,” said Andy Ferrell, PCI CEO.
Mr. Ewan was most recently a Senior Director, Engineering Technical Support for MedImmune. Previously he was Executive Director, Corporate Engineering with Amgen. His responsibilities included all discipline functions supporting world-wide projects for Amgen. Leading up to Amgen, he served as Vice-President of Pharmaceutical Operations, Skanska USA Building. Mr. Ewan previously was employed as Director of Engineering for GlaxoSmithKline for 14 years, responsible for an integrated team of project managers, engineers, and cost/schedulers delivering capital projects in GSK's manufacturing company. Prior to coming to GSK, Mr. Ewan was Senior Project Manager at Genentech, responsible for one of the first manufacturing facilities for the emerging biotechnology industry of the 80’s.
A graduate of Clemson University in South Carolina and Drexel University in Philadelphia, Mr. Ewan recently completed the Executive Program at Georgetown University in Leadership Coaching. He chaired an international commission to certify professional pharmaceutical engineers for the ISPE, (International Society of Pharmaceutical Engineers) and is a member of The International Coach Federation holding the credential, Associate Certified Coach. He was on the Board of Directors for the ISPE Chesapeake Bay Area Chapter and is currently on the Board of the ISPE CaSA Chapter.
“As I join PCI’s Board, I am looking forward to contributing my knowledge and experience to keep PCI growing and thriving as they serve an increasing customer base nationwide,” said Mr. Ewan.
To see more on the PCI Board Members, visit http://www.pci-llc.com/about/pci-leadership-team/.
PCI was founded in 1996 with a vision of becoming the best consulting and technical services firm in the life sciences industry. The company’s core expertise is calibration and maintenance compliance for FDA-regulated manufacturing facilities and laboratories. PCI’s mission is to provide personalized customer service, exceptional and quality documentation to their customers while always preserving the integrity and ingenuity of performance. The company places high value on honesty, integrity, pride, self-esteem and teamwork. PCI take these values and mission as their primary focus in creating the ultimate result for clients: total compliance in the product quality life cycle.
PCI offers a comprehensive selection of quality services that include Calibration & Maintenance Consulting, Process & Analytical Equipment Calibrations, and ISO 17025 Metrology Laboratory. The company’s six regional offices are located in Boston, Gaithersburg, Indianapolis, Raleigh, San Francisco and Seattle. Find PCI on the web at http://www.pci-llc.com/.